The new medical domain represents hybrid chains. These kinds of synthetic entities integrate sections derived from various protein families, allowing for distinct pharmacological characteristics. The method presents a https://chimerapeptides894910.zeeblogger.com/61978570/chimera-peptides-a-novel-therapeutic-frontier